Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Whole blood gene expression moderates associations between AD biomarkers and cognitive decline in cognitively unimpaired older adults.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Klinger Hannah M, Seto Mabel, Janve Vaibhav A, Brown Jane A, Clifton Michelle, Birkenbihl Colin, Coughlan Gillian T, Townsend Diana L, Properzi Michael, Zyski Jane, Wang Ting-Chen, Amariglio Rebecca E, Papp Kathryn V, Rentz Dorene M, Yang Hyun-Sik, Chhatwal Jasmeer, Donohue Michael C, Raman Rema, Rissman Robert A, Aisen Paul, Johnson Keith A, Sperling Reisa A, Dumitrescu Logan, Hohman Timothy, Buckley Rachel F
Аннотация
INTRODUCTION: Early biological pathways explaining the risk for Alzheimer's disease (AD)-related cognitive decline remain poorly understood.
METHODS: Using linear mixed-effects models, we investigated whether whole blood gene expression (RNA sequencing) moderates the relationship between AD biomarkers measured by amyloid beta (Aβ) and tau-PET (positron emission tomography) imaging and longitudinal cognition in 770 cognitively unimpaired older adults (Agemean = 71.3, 62% female) from Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) (A4/LEARN).
RESULTS: We identified protective and AD risk-related gene expression signatures on the autosome and X chromosome. Six genes (ngenes(%); 2(33%) X-linked) interacted with Aβ-PET, whereas 103 genes (3(3%) X-linked) interacted with neocortical tau-PET, to influence cognitive decline. A total of 110 genes (17(15%) X-linked) and 3156 genes (121(4%) X-linked) were moderated by both sex and Aβ- or tau-PET, respectively. Pathway enrichment analyses reflected immunity, protein synthesis, and lipid metabolism.
DISCUSSION: These findings underscore the importance of peripheral transcriptomic markers in identifying sex-differentiated pathways related to risk of and protection from cognitive decline in preclinical AD.
METHODS: Using linear mixed-effects models, we investigated whether whole blood gene expression (RNA sequencing) moderates the relationship between AD biomarkers measured by amyloid beta (Aβ) and tau-PET (positron emission tomography) imaging and longitudinal cognition in 770 cognitively unimpaired older adults (Agemean = 71.3, 62% female) from Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) (A4/LEARN).
RESULTS: We identified protective and AD risk-related gene expression signatures on the autosome and X chromosome. Six genes (ngenes(%); 2(33%) X-linked) interacted with Aβ-PET, whereas 103 genes (3(3%) X-linked) interacted with neocortical tau-PET, to influence cognitive decline. A total of 110 genes (17(15%) X-linked) and 3156 genes (121(4%) X-linked) were moderated by both sex and Aβ- or tau-PET, respectively. Pathway enrichment analyses reflected immunity, protein synthesis, and lipid metabolism.
DISCUSSION: These findings underscore the importance of peripheral transcriptomic markers in identifying sex-differentiated pathways related to risk of and protection from cognitive decline in preclinical AD.